Is Creative Medical Technology Holdings Inc (CELZ) overvalued? · rev $11.0K
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ.
This page asks whether Creative Medical Technology Holdings Inc (CELZ) looks expensive on cached numbers — not a short thesis.
Latest reported CELZ revenue for 2024-12-31 was $11.0K. Net income was -$5.5M. Revenue was up 22.2% from 2023-12-31 to 2024-12-31. CELZ currently screens at market cap $8.3M.
CELZ currently screens at market cap $8.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CELZ 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CELZ stock page for the full model, not this heading.
Not investment advice.